mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.02 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.03 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |